PegBio (HKG:2565) said the China Securities Regulatory Commission has issued a filing notice for its Hong Kong share full circulation application, according to a Thursday bourse filing.
Shares of the biotechnology company were up nearly 1% in Friday morning trade.
The filing covers the conversion of about 101.7 million unlisted shares into Hong Kong shares.
PegBio will apply to the Hong Kong stock exchange for the listing of the converted shares, with further details of the plan yet to be finalized.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments